DEBORAH DUNHAM: Open Payments
NPI 1518079037 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 47 payments from 14 companies in 2025. Trend: 2023 $1,496 · 2024 $2,087 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $275 |
| BIOTRONIK INC. | 4 | $243 |
| Merck Sharp & Dohme LLC | 7 | $209 |
| E.R. Squibb & Sons, L.L.C. | 4 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $172 |
| SCPHARMACEUTICALS INC. | 8 | $156 |
| CVRx, Inc. | 1 | $120 |
| Abbott Laboratories | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| ABIOMED | 1 | $40 |
Products named: FARAPULSE, VERQUVO, Kerendia, FUROSCIX, CAMZYOS, Barostim Neo System, AMVIA EDGE, Renamic Neo.
Industry payments across FL — which companies pay providers there.
